The U.S. Food and Drug Administration issued new guidance for vaccine makers as the regulatory agency is preparing for the possibility of needing to approve Covid-19 booster shots against variants of the SARS-CoV-2 virus.
U.S. public health officials said a second Covid-19 shot could be administered as much as six weeks apart from the first one in situations where it was not possible to get a booster dose immediately.
A U.S. Centers for Disease Control and Prevention advisory panel on Dec. 12 recommended the nation’s first COVID-19 vaccine, helping clear the way for public health authorities to begin the largest vaccination campaign in U.S. history.
After months of urging the public to wear masks and facial coverings to help stop infected people from spreading Covid-19, the Centers for Disease Control and Prevention (CDC) stated in newly released guidance that masks also protected the mask wearer from being infected.
White House Reverses Course, Approves New FDA COVID-19 Vaccine Guidelines Published: Oct. 7, 2020 By Alex Keown BioSpace The White House has reversed its position on new vaccine guidelines proposed by the U.S. Food and Drug Administration. The approval of the new guidelines all but assures that a vaccine for the novel coronavirus that has […]
White House officials said they would block new vaccine guidance that would delay hurried approvals ahead of the Nov. 3 election.
President Donald Trump signaled the White House may attempt to override a more stringent guidance for Emergency Use Authorization of a vaccine for the novel coronavirus under consideration by the U.S.Food and Drug Administration (FDA).
The U.S. Food and Drug Administration is expected to issue a new and more stringent guidance regarding a potential Emergency Use Authorization (EUA) for a Covid–19 vaccine.